Teva signs $33.75bn mega-loan for Allergan deal
Teva, the New York-listed Israeli pharmaceutical company, has completed and signed $33.75bn of loans for its acquisition of Allergan Generics.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: